Literature DB >> 26010072

Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B-cell lymphoma.

Hugo J A Adams1, Thomas C Kwee1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26010072     DOI: 10.1002/ajh.24061

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.

Authors:  Tzu-Hua Chen-Liang; Taida Martín-Santos; Andrés Jerez; Guillermo Rodríguez-García; Leonor Senent; Cristina Martínez-Millán; Begoña Muiña; Mayte Orero; Anabel Teruel; Alejandro Martín; Joaquín Gómez-Espuch; Kyra Kennedy; Carmen Benet; José María Raya; Marta Fernández-González; Fátima de la Cruz; Marta Guinot; Carolina Villegas; Isabel Ballester; Mónica Baile; María Moya; Javier López-Jiménez; Laura Frutos; José Luis Navarro; Jon Uña; Rosa Fernández-López; Carolina Igua; José Contreras; Raquel Sánchez-Vañó; María Del Puig Cozar; Pilar Tamayo; Jorge Mucientes; José Javier Sánchez-Blanco; Elena Pérez-Ceballos; Francisco José Ortuño
Journal:  Cancer Med       Date:  2017-09-27       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.